The role of caspase-8 in resistance to cancer chemotherapy

Thornberry, 1998, Caspases: enemies within, Science, 281, 1312, 10.1126/science.281.5381.1312 Reed, 1999, Dysregulation of apoptosis in cancer, J Clin Oncol, 17, 2941, 10.1200/JCO.1999.17.9.2941 Scaffidi, 1998, Two CD95 (APO-1/Fas) signaling pathways, EMBO J, 17, 1675, 10.1093/emboj/17.6.1675 Hengartner, 2000, The biochemistry of apoptosis, Nature, 407, 770, 10.1038/35037710 Ashkenazi, 1998, Death receptors: signaling and modulation, Science, 281, 1305, 10.1126/science.281.5381.1305 Chinnaiyan, 1996, FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis, J Biol Chem, 271, 4961, 10.1074/jbc.271.9.4961 Hsu, 1995, The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation, Cell, 81, 495, 10.1016/0092-8674(95)90070-5 Kischkel, 1995, Cytotoxicity-dependent APO-1 (Fas/CD95)-associated protein form a death-inducing signaling complex (DISC) with the receptor, EMBO J, 14, 5579, 10.1002/j.1460-2075.1995.tb00245.x Yang, 1998, Autoproteolytic activation of pro-caspases by oligomerization, Mol Cell, 1, 319, 10.1016/S1097-2765(00)80032-5 Muzio, 1998, An induced proximity model for caspase-8 activation, J Biol Chem, 273, 2926, 10.1074/jbc.273.5.2926 Martin, 1998, Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal, J Biol Chem, 273, 4345, 10.1074/jbc.273.8.4345 Nagata, 1997, Apoptosis by death factor, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7 Krammer, 2000, CD95's deadly mission in the immune system, Nature, 407, 789, 10.1038/35037728 Green, 2000, Apoptotic pathways: paper wraps stone blunts scissors, Cell, 102, 1, 10.1016/S0092-8674(00)00003-9 Tang, 2000, Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis, J Biol Chem, 275, 9303, 10.1074/jbc.275.13.9303 Korsmeyer, 1999, BCL-2 gene family and the regulation of programmed cell death, Cancer Res, 59, 1693s Friesen, 1996, Involvement of the CD-95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells, Nat Med, 2, 574, 10.1038/nm0596-574 Friesen, 1997, Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells, Leukemia, 11, 1833, 10.1038/sj.leu.2400827 Lacour, 2001, Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis, Cancer Res, 61, 1645 Seol, 2001, Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis, Cancer Res, 61, 1138 Mitsiades, 2001, Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducingligand and express death receptor 4 and death receptor 5, Cancer Res, 61, 2704 Dirsch, 2001, Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2, Cancer Res, 61, 5817 Walczak, 2000, Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells, Cancer Res, 60, 3051 Petak, 2000, Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis, Clin Cancer Res, 6, 4119 Eischen, 1997, Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions, Blood, 90, 935, 10.1182/blood.V90.3.935 McGahon, 1998, Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system, Br J Haematol, 101, 539, 10.1046/j.1365-2141.1998.00745.x Ferreira, 2000, Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway, Clin Cancer Res, 6, 203 Sun, 1999, Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis, J Biol Chem, 274, 5053, 10.1074/jbc.274.8.5053 Ferreira, 2000, Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460, Cancer Res, 60, 7133 Seki, 2000, Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma, Cancer Chemother Pharmacol, 45, 199, 10.1007/s002800050030 Kitamura, 2000, Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis, Leukemia, 14, 1743, 10.1038/sj.leu.2401900 Renes, 2000, The (patho) physiological functions of the MRP family, Drug Resist Updates, 3, 289, 10.1054/drup.2000.0156 Poulaki, 2001, Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2, Cancer Res, 61, 4864 Teitz, 2000, Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN, Nat Med, 6, 529, 10.1038/75007 Grotzer, 2000, Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression, Oncogene, 19, 4604, 10.1038/sj.onc.1203816 Chadderton, 2000, Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells, Breast Cancer Res Treat, 59, 231, 10.1023/A:1006344200094 Mandruzzato, 1997, A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma, J Exp Med, 186, 785, 10.1084/jem.186.5.785 Irmler, 1997, Inhibition of death receptor signals by cellular FLIP, Nature, 388, 190, 10.1038/40657 Scaffidi, 1999, The role of c-FLIP in modulation of CD95-induced apoptosis, J Biol Chem, 274, 1541, 10.1074/jbc.274.3.1541 Medema, 1999, Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein, J Exp Med, 190, 1033, 10.1084/jem.190.7.1033 Zhang, 1999, Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma, Cancer Res, 59, 2747 Djerbi, 1999, The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors, J Exp Med, 190, 1025, 10.1084/jem.190.7.1025 Griffith, 1998, Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells, J Immunol, 161, 2833, 10.4049/jimmunol.161.6.2833 Kim, 2000, Molecular determinants of response to TRAIL in killing of normal and cancer cells, Clin Cancer Res, 6, 335 Zhang, 2000, BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins, Proc Natl Acad Sci USA, 97, 2597, 10.1073/pnas.97.6.2597 Borst, 2001, Does resistance to apoptosis affect clinical response to antitumor drugs?, Drug Resist Updates, 4, 129, 10.1054/drup.2001.0187 Brown, 2001, Apoptosis: mediator or mode of cell killing by anticancer agents?, Drug Resist Updates, 4, 135, 10.1054/drup.2001.0193 Schmitt, 2001, Apoptosis is critical for drug response in vivo, Drug Resist Updates, 4, 132, 10.1054/drup.2001.0188 Ruiz-Ruiz, 2000, Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program, Cancer Res, 60, 5673 Yamada, 2000, Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas-resistant adult T-cell leukemia cell lines, Eur J Haematol, 64, 315, 10.1034/j.1600-0609.2000.90110.x Fulda, 2001, Sensitization for death-receptor or drug-induced apoptosis by restoration of caspase-8 expression through demethylation or caspase-8 gene transfer, Proc Am Assoc Cancer Res, 42, 274